Oligo‐astheno‐teratozoospermia is frequently reported in men from infertile couples. Its etiology remains, in the majority of cases, unknown with a variety of factors to contribute to its pathogenesis. The aim of this European Academy of Andrology guideline was to provide an overview of these factors...
Hypertensive disorders of pregnancy are an
important cause of severe morbidity, long-term
disability and death among both pregnant women
and their babies, and account for approximately
14% of all maternal deaths worldwide. Improving
care for women around the time of childbirth is
a necessary step towards...
The Department of Reproductive Health and Research of the World Health Organization
gratefully acknowledges the contributions of many individuals and organizations to
the updating of these recommendations. Work on this update was coordinated by
Olufemi Oladapo, Joshua Vogel and A. Metin Gülmezoglu of th...
Hembree, W. C;
Cohen-Kettenis, P. T;
Gooren, L;
Hannema, S. E;
Meyer, W. J;
Murad, M. H;
Rosenthal, S. M;
Safer, J. D;
Tangpricha, V;
T'Sjoen, G. G.
OBJECTIVE: To update the "Endocrine Treatment of Transsexual Persons: An Endocrine Society Clinical Practice Guideline," published by the Endocrine Society in 2009. PARTICIPANTS: The participants include an Endocrine Society-appointed task force of nine experts, a methodologist, and a medical writer. ...
Al-Mandeel, H. M;
Sagr, E;
Sait, K;
Latifah, H. M;
Al-Obaid, A;
Al-Badawi, I. A;
Alkushi, A. O;
Salem, H;
Massoudi, N. S;
Schunemann, H;
Mustafa, R. A;
Brignardello-Petersen, R.
BACKGROUND: Cervical cancer is the third most common gynecological malignancy in Saudi women with an estimated incidence rate of 1.9 cases per 100 000 women-years. More than 40% of cervical cancer cases are diagnosed at advanced stages due to lack of a routine screening program in Saudi Arabia. Thus, nat...
This document is part of the process for improving the quality of care in family planning. Medical eligibility criteria for contraceptive use (MEC), the first edition of which was published in 1996, presents current WHO guidance on the safety of various contraceptive methods for use in the context of spe...
These guidelines were produced by the Department of Reproductive Health and Research (RHR), World Health Organization (WHO), under the leadership of Dr Claudia García-Moreno. The expertise and support of many people have made the development of these guidelines possible. The guideline development proces...
This document recommends a proactive approach to HIV testing and counselling by care providers in these settings. Offers basic operational guidance on HIV testing and counselling in settings attended by people who inject drugs (PWID)....
